| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.017 | 0.9 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |